Ovarian Cancer Registry (OVAR); A study protocol for retrospective data collection in Colombian patients with ovarian cancer

Abstract
Ovarian cancer is one of the leading causes of death from gynecologic cancer. In Colombia, as in the world, its diagnosis is made in late stages due to the absence of specific symptoms of this disease.
Objective: The objective of the Ovarian Cancer Registry is (i) to collect clinical and histopathological data using a standardized protocol, (ii) to characterize these patients clinically and histopathological to optimize the diagnosis and treatment, to describe these clinical aspects, which will allow us to understand the clinical particularities of this disease better.
Methods: The Ovarian Cancer Registry is designed as a retrospective for data collection on OVAR patients. All patients under medical care at the Hospital Universitario Mayor Méderi and who have arrived in three possible routes or scenarios: (i) outpatient care, (ii) assessment in emergency services and (iii) references to the oncology service. The OVAR will have information on patients who consulted the Major Hospital from the first of January 2021 with CIE10 C56X and C482.
Ethics and dissemination: The University of Rosario Ethics Committee approved registry protocol V02 (08/feb/24) No. 2541-CV1830 (Bogotá, Colombia). Registry leaders acknowledge their ongoing ethical responsibilities for all research using this data.
Conclusion: The data from the Ovarian Cancer Registry will be instrumental in establishing optimal management strategies for OC patients, laying the groundwork for future guideline recommendations, and shaping the direction of upcoming research on the Colombian population.